AIDDD Summit 2025
The leading global event focused solely on AI in drug discovery and development
Boston, US
November 18-20, 2025
The AI-Driven Drug Discovery & Development Summit is the premier event for innovators, researchers, and industry leaders seeking to harness the power of artificial intelligence to accelerate every stage of drug development. This summit brings together the brightest minds in pharma, biotech, and technology to share the latest breakthroughs, case studies, and best practices in AI-enabled drug design, lead optimization, and synthesis planning. Whether you’re looking to streamline your workflows, reduce costs, or discover new molecules with greater speed and precision, this event is your gateway to the future of smarter, faster, and more sustainable drug discovery.
Meet SYNTHIA® & AIDDISON™—Your Complete Drug Design Toolkit
At our booth, you’ll discover how the integration of SYNTHIA® Retrosynthesis Software and AIDDISON™ generative AI creates an end-to-end solution for modern drug discovery. AIDDISON™ empowers you to design novel molecules using advanced generative AI, predictive insights, and 3D modeling, while SYNTHIA® enables you to rapidly plan and optimize synthetic routes using expert-coded chemistry rules and real-world data. Together, these platforms bridge the gap between virtual molecule design and practical laboratory synthesis, allowing you to go from prediction to pre-clinical candidate faster than ever before. You’ll see live demonstrations of how you can generate new ideas, assess synthetic feasibility, and even build a shopping list of starting materials—all in one seamless workflow.
Why Should You Come?
- Accelerate Innovation: Learn how SYNTHIA® and AIDDISON™ can reduce manual labor, cut costs, and dramatically speed up the path from idea to synthesis. Case studies show up to 93% reduction in manual working time when combining automated route planning and synthesis execution.
- Enhance Sustainability: Discover how SYNTHIA® supports green chemistry by helping you design more efficient, less wasteful, and safer synthetic routes—quantitatively evaluated using industry-leading tools like DOZN™.
- Unlock New Possibilities: Explore how AI-driven retrosynthesis and de novo molecule design can help you generate innovative IP, optimize ADMET properties, and overcome synthetic bottlenecks that limit traditional approaches.
Collaborate & Customize: See how our cloud-based, ISO 27001-certified platforms can be tailored to your specific needs, integrated into your existing workflows, and scaled for projects of any size—from single targets to high-throughput virtual screening.
Don’t miss your chance to experience the next generation of digital chemistry solutions. Visit our booth at the AI-Driven Drug Discovery & Development Summit and pioneer your pathway to smarter, faster, and more sustainable drug discovery!
